Microbix Biosystems Inc. has seen a mixed performance this week in the healthcare sector.
Microbix Biosystems Inc. (MBX.TO) closed at C$0.30, reflecting a 0.88% increase on the last trading day, but the stock is down 4.17% over the past week. The company has been in the news recently due to its financial performance and product advancements, which could impact its stock performance moving forward.
Advertisement
Microbix Biosystems Inc.
MBX.TO
MBX.TO
Microbix Biosystems Inc.
WealthAwesomeMarket cap
$41.09M
52W high
$0.33
52W low
$0.21
1W change
-4.17%
Beta
0.57
Analyst Price Targets
Based on analyst covering MBX
Wall Street analysts forecast MBX stock price to rise 39.1% over the next 12 months.
Consensus
BullishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$0.40
+39.1% Upside
Current Price
C$0.29
Last close
Analyst ratings and price targets are updated periodically. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on MBX's historical volatility
30-Day Vol
48.0%
Annualized
90-Day Vol
49.1%
Annualized
Trend (90d)
+34.2%
Annualized drift
90d Mean
C$0.32
Expected price
| Horizon | Expected | 68% Range (1ฯ) |
|---|---|---|
| 30 trading days | C$0.30 | C$0.25 โ C$0.35 |
| 60 trading days | C$0.31 | C$0.25 โ C$0.39 |
| 90 trading days | C$0.32 | C$0.24 โ C$0.43 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ยฑ1ฯ, 95% band = ยฑ2ฯ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Advertisement
Investor takeaway: Investors may want to keep an eye on Microbix's upcoming earnings and any developments in their product pipeline, especially considering their recent revenue growth and efforts to enhance manufacturing capabilities.
C$0.40
Analysts have set an average target price of C$0.40 for Microbix, suggesting a potential upside of 33.3% from the current price.
Bull case
Microbix reported Q3 revenues of $4.1 million, showing a 17% growth compared to the same quarter last year. This growth may boost investor confidence in the company's trajectory.
Bear case
Despite the revenue growth, the company is still facing a negative profit margin of -31.7%. This raises concerns about its long-term profitability and financial stability.
Recent Performance Overview
Microbix Biosystems Inc. (MBX.TO) closed at C$0.30, marking a 1-day increase of 0.88%. However, the stock has declined by 4.17% over the past week and dropped 7.26% over the month. Year-to-date, the stock has shown a positive trend with an increase of 19.79%.
Catalysts and Company News
Advertisement
Recently, Microbix reported its Q3 fiscal 2026 results, showcasing revenues of $4.1 million, a 17% increase compared to the same quarter last year. This performance highlights the company's ongoing growth despite operational challenges. No major news has been reported in the past week that could have significantly influenced the stock price.
Technical Picture
The technical indicators for Microbix show a last close of C$0.30, which aligns closely with its 50-day moving average of C$0.30, indicating stability. The 200-day moving average is at C$0.26, suggesting a positive trend over the longer term. The stock has fluctuated within a 52-week range of C$0.21 to C$0.33, currently sitting at 75% of this range. With a beta of 0.57, the stock is considered less volatile compared to the broader market, but recent trading volume has been lower than average, with 18,000 shares traded against a 20-day average of 34,083 shares.
Insider Activity
No recent insider activity has been reported for Microbix Biosystems Inc., which may suggest a period of stabilization as the company focuses on its growth initiatives.
Price Action Summary
Microbix Biosystems Inc. closed the week at C$0.30, reflecting a 1-day increase of 0.88%. With ongoing developments in their product offerings and financial performance, investors should stay informed on future earnings reports and market conditions.
Best next step
Keep exploring this topic
If you want to go deeper, these are the most useful follow-up pages and tools for this topic.
Broker comparison
Best trading platforms in Canada
Compare $0-commission brokers before you act on a ticker story.
Safe cash
Best GIC rates in Canada
If the story makes you want to de-risk, compare guaranteed rates next.
HISA roundup
Best high-interest savings accounts
Keep dry powder in a no-fee savings account instead of chequing.
TFSA room
Check TFSA contribution room
Shelter the next contribution before you buy.
Advertisement
Wealth Awesome
Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.
View Full Profile โโ Reviewed by Certified Financial Professionals
This content has been reviewed by CFAยฎ charterholders and Certified Financial Planners (CFPยฎ) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.
Why these credentials matter: CFAยฎ charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFPยฎ professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.
โ ๏ธ Professional Disclaimer
This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.
